Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

MRK


Fundamental

Company: Merck & Co Inc
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: USA
Exchange: NYSE
Index: DJIA, S&P 500
P/E: 20.54
EPS (ttm): 4.77
Insider Own: 0.09%
Shs Outstand: 2.53B
Perf Week: -3.87%
Market Cap: 244.37B
Forward P/E: 10.39
EPS next Y: 9.44
Insider Trans: 0.00%
Shs Float: 2.53B
Perf Month: 0.63%
Income: 12.15B
PEG: 0.73
EPS next Q: 1.81
Inst Own: 78.92%
Short Float: 1.30%
Perf Quarter: -15.20%
Sales: 62.89B
P/S: 3.89
EPS this Y: 412.48%
Inst Trans: -0.04%
Short Ratio: 2.93
Perf Half Y: -26.26%
Book/sh: 17.58
P/B: 5.58
EPS next Y Percentage: 22.00%
ROA: 10.83%
Short Interest: 32.79M
Perf Year: -6.94%
Cash/sh: 5.87
P/C: 16.70
EPS next 5Y: 28.00%
ROE: 28.33%
52W Range From: 94.48
52W Range To: 134.63
Perf YTD: -10.06%
Dividend Est.: 3.10 (3.16%)
P/FCF: 16.47
EPS past 5Y: -42.70%
ROI: 15.28%
52W High: -27.17%
Beta: 0.41
Dividend TTM: 3.12 (3.18%)
Quick Ratio: 1.15
Sales past 5Y: 7.72%
Gross Margin: 73.03%
52W Low: 3.78%
ATR (14): 2.20
Dividend Ex-Date: Dec 16, 2024
Current Ratio: 1.36
EPS Y/Y TTM: 163.70%
Oper. Margin: 23.00%
RSI (14): 40.50
Volatility W: 2.19%
Volatility M: 2.19%
Employees: 72000
Debt/Eq: 0.86
Sales Y/Y TTM: 8.17%
Profit Margin: 19.32%
Recom: 1.69
Target Price: 128.00
Option/Short: Yes / Yes
LT Debt/Eq: 0.79
EPS Q/Q: -33.34%
Payout: 2065.60%
Rel Volume: 2.61
Prev Close: 99.52
Sales Surprise: 1.11%
EPS Surprise: 5.80%
Sales Q/Q: 4.42%
Earnings: Oct 31 BMO
Avg Volume: 11.21M
Price: 98.05
SMA20: -2.97%
SMA50: -4.22%
SMA200: -16.85%
Trades:
Volume: 29,270,813
Change: -1.48%

Technical:


Latest News:

Merck & Co., Inc. (MRK) Bank of America Global Healthcare Conference (Transcript) somewhat bullish
MRK

Summary: Merck & Co., Inc. provides an update on their strong performance and pipeline progress during the Bank of America Global Healthcare Conference. They have shown growth in the second quarter and raised their full-year guidance.

Full article
2024-09-18T17:34:46Z
Eli Lilly is a new large-cap pharma top pick at Wells Fargo - Investing.com very bullish
LLY VRTX ABBV GILD AMGN MRK BMY

Summary: Wells Fargo named Eli Lilly & Co. as its new top pick among large-cap pharmaceutical stocks, highlighting its potential for significant upside and strong pipeline.

Full article
2024-08-20T22:10:39Z
Discover Life Science Customers' Expectations and - GlobeNewswire neutral
ABCM A BDX BIO BTSC BRKR GLW C EP GIL HMLTN ILMN INTE MTD MRK NEB REVT PMG QGEN SRT TKRA TMO THO USAS VWR WAT

Summary: The report '2024 Perceptions in Environmental Sustainability in the Life Sciences' has been added to ResearchAndMarkets.com's offering. It details findings of research exploring trends in customers' perceptions and expectations of environmental sustainability in the life sciences industry.

Full article
2024-08-07T13:08:33Z
Merck's vaccine approval poses threat to one of Pfizer's top-selling products - Morningstar somewhat bullish
MRK PFE

Summary: Merck gains U.S. regulatory approval for Capvaxive pneumococcal vaccine, set to compete with Pfizer's Prevnar 20. Merck expects to provide broader protection compared to existing vaccines, with expected availability in late 2024. Pfizer remains confident with its 98% market share in the adult pneumococcal vaccine segment.

Full article
2024-06-17T21:10:42Z
FDA Action Alert: Merck, BMS, Sarepta and More | BioSpace neutral
MRK ARGX BMY

Summary: FDA has a busy week ahead with six target action dates. Merck awaiting verdict on pneumococcal shot, Argenx seeks approval for Vyvgart Hytrulo in CIDP, BMS targets Krazati expansion into CRC among other drug applications.

Full article
2024-06-17T04:10:08Z
Dow Breaks Support Ahead Of Fed Report; Tesla Shareholders Vote On Elon Musk's Pay Package somewhat bearish
TSLA AI UNH CRM MRK COP MRO ANF VIK CAVA PATH NTNX PSTG CHWY AAL

Summary: Stock market indexes remained lower today amidst growing concerns of inflation ahead of a key Fed report, impacting major indexes and sectors like health care. The Dow Jones and S&P 500 declined, while the Nasdaq had a slightly better performance. Yield on the 10-year Treasury note jumped, leading to worries about potential rate cuts being pushed back. Companies such as Tesla, C3.ai, UnitedHealth Group, and Salesforce experienced stock movements related to earnings, acquisitions, or market sentiment.

Full article
2024-05-29T18:05:23Z
J&J, Merck Break Out The Big Bucks In Separate Billon-Dollar Deals - KFF Health News somewhat bullish
JNJ MRK INSM

Summary: J&J and Merck are making billion-dollar deals to acquire rights to experimental treatments, with J&J acquiring a skin disorder treatment for $1.25 billion and Merck nearing a $1.3 billion deal for EyeBio. Insmed Incorporated's lung disease drug sees success in a Phase 3 trial, resulting in a surge in share price.

Full article
2024-05-29T12:50:20Z
Dow Jones Futures: AI Stock Palo Alto Plunges On Earnings; Nvidia Earnings, Fed Minutes Loom neutral
PANW NVDA ZM HOOD PDD TSM TTD TW JPM MRK AAPL MSFT

Summary: Dow Jones futures and major indices were little changed ahead of the stock market open. Artificial intelligence stock Palo Alto Networks plunged more than 9% on earnings, while Nvidia earnings and Federal Reserve minutes are due later this week. Other key earnings movers include Zoom Video Communications. Current economic reports include existing-home and new-home sales, and PMI data. JPMorgan Chase, Merck, Apple, and Microsoft are among notable stocks.

Full article
2024-05-20T20:53:51Z
Dow Jones Rises As Nvidia Rallies On Price-Target Hikes | Investor's Business Daily neutral
NVDA LI QQQ SPY AAPL MSFT TSLA PDD TSM TTD TW JPM MRK

Summary: The Dow Jones Industrial Average dropped while other major indexes rose as Wall Street seeks more record highs. Among the gainers was Nvidia after analysts raised its price target, while Li Auto tumbled due to an earnings miss. The 10-year Treasury yield ticked higher and oil prices dipped. Investors are awaiting the release of Federal Reserve minutes this week.

Full article
2024-05-20T12:36:27Z
Washington Federal Bank to Sell Real Estate Loans to BoA - PYMNTS.com somewhat bearish
BAC JPM NMRK

Summary: Washington Federal Bank, a subsidiary of WaFd, is selling commercial multi-family real estate loans to Bank of America for $2.9 billion to reduce exposure in a troubled sector. The commercial real estate sector has been challenged by higher borrowing costs and lower occupancy rates, causing concern among investors and regulators.

Full article
2024-05-18T00:49:01Z
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E neutral
AVGO MRK ABNB

Summary: Broadcom, Merck & Co., and Airbnb are among the top stocks featured in the Zacks Analyst Blog. Broadcom expects strong revenue growth in fiscal 2024, especially in AI and networking segments. Merck is experiencing growth driven by products like Keytruda, but faces challenges in generic competition and competitive pressures. Airbnb's positive trend in Gross Booking Value and strong momentum in app downloads are positives, but it faces volatility in travel demand and competition in the online travel space.

Full article
2024-05-16T20:00:48Z
Pfizer to pay $250M over Zantac cancer risk lawsuits - Audacy somewhat bearish
PFE GSK SANOFI MRK BMY

Summary: Pfizer to pay $250 million to settle over 10,000 lawsuits related to Zantac, a heartburn drug linked to cancer risk, with ongoing discussions and legal battles among pharmaceutical companies related to the drug's liability.

Full article
2024-05-16T18:23:41Z